CDKN2A and neoplasm: CDKN2A encodes the P16 gene involved in a series of cellular pathways, including promoting tumor cell proliferation, inhibiting tumor cell apoptosis, inducing tumor stromal angiogenesis and reducing cancer cell sensitivity to chemotherapy [6].